Fecal Microbiota Transplantation on Type 2 Diabetes Mellitus
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01790711|
Recruitment Status : Unknown
Verified November 2014 by Faming Zhang, The Second Hospital of Nanjing Medical University.
Recruitment status was: Enrolling by invitation
First Posted : February 13, 2013
Last Update Posted : November 24, 2014
|Condition or disease||Intervention/treatment||Phase|
|Efficiency Methodology||Procedure: FMT through mid-gut||Phase 2 Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||30 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||The Efficiency of Fecal Microbiota Transplantation on Type 2 Diabetes Mellitus|
|Study Start Date :||October 2012|
|Estimated Primary Completion Date :||May 2015|
|Estimated Study Completion Date :||June 2015|
Experimental: FMT by endoscopy
Once, fresh or frozen bacteria
Procedure: FMT through mid-gut
Other Name: FMT through mid-gut by gastroscope
- The Efficiency of FMT on T2DM [ Time Frame: Up to 24 months ]Confirmed by the tests of blood glucose level, OGTT, HACb1 and C-peptide.
- Durability [ Time Frame: Up to 12 months ]Measure the durability of the therapy effects.Based on the tests of blood glucose level, HACb1 and C-peptide. BMI also will be observed.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01790711
|Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University|
|Nanjing, Jiangsu, China, 210011|